Roundhill · holdings as of 2026-10-13

CHAT

Roundhill Generative AI & Technology ETF

Last / close
$84.63
Day change
-$4.54 · -5.09%
Volume
Not reported
NAV
$88.76
Premium / discount
+0.46%
After hours · updated 16:00:00 ET · As of Oct 14, 2026, 4:00 PM EDTMarket quote receipt →Issuer NAV · 2026-10-13 →

Generative-AI infrastructure, platforms, and software drawn from Roundhill's complete dated daily holdings file.

Veridion read
58Middle range · medium confidence
Fund score · valuation-exempt

4/5 applicable factors · 2026-10-14 · methodology receipt

Published holdings
48
Primary source
Issuer fund page →
01

Fund observations

Market and fund figures, each dated to its source.

A blank cell means the field does not have a qualified source. Price-derived AUM change is never relabeled as fund flow.

AUM
$1.85B
2026-10-13
Expense ratio
0.75%
2026-10-13
Inception
2023-05-18
2026-10-13
Holdings
48
2026-10-13
YTD return
+47.66%
2026-10-13
1Y return
+43.48%
2026-10-13

Every weight here comes straight from the issuer's filing — not our estimate.

02

Complete issuer book

All 48 holdings

Every row resolves to the issuer file dated 2026-10-13. Paid overlays add Scores and historical weight changes without altering the public holdings structure.

Public disclosures

Congress activity in CHAT

No receipt-qualified filings found.

03

Comparative read

Weight-adjusted Score and shared-book overlap.

The fund Score is a weighted aggregation of covered holdings, not a separately trained ETF model. Overlap uses only published issuer books.

01AIQ29.92%15 shared holdings
02ARTY27.52%12 shared holdings
03XLK27.45%13 shared holdings
04SMH24.40%9 shared holdings
05SOXX23.96%10 shared holdings
06AIPO18.83%11 shared holdings
07XSD16.38%8 shared holdings
08ARKQ15.24%4 shared holdings

Coverage note. Net flows, AUM change are not reported with a qualified receipt; 48 holding quotes are unresolved; the Score and ownership-change overlays are withheld from the free response. Open the issuer holdings receipt →

Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.